153 related articles for article (PubMed ID: 19041242)
1. Design and synthesis of 4-aryl-4-oxobutanoic acid amides as calpain inhibitors.
Zhang Y; Jung SY; Jin C; Kim ND; Gong P; Lee YS
Bioorg Med Chem Lett; 2009 Jan; 19(2):502-7. PubMed ID: 19041242
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of calpain inhibitory 6-pyridone 2-carboxamide derivatives.
Lee KY; Lee KS; Jin C; Lee YS
Eur J Med Chem; 2009 Mar; 44(3):1331-4. PubMed ID: 18396356
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors.
Nam DH; Lee KS; Kim SH; Kim SM; Jung SY; Chung SH; Kim HJ; Kim ND; Jin C; Lee YS
Bioorg Med Chem Lett; 2008 Jan; 18(1):205-9. PubMed ID: 18024028
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors.
Lee KS; Seo SH; Lee YH; Kim HD; Son MH; Chung BY; Lee JY; Jin C; Lee YS
Bioorg Med Chem Lett; 2005 Jun; 15(11):2857-60. PubMed ID: 15911268
[TBL] [Abstract][Full Text] [Related]
5. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B.
Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y
Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812
[TBL] [Abstract][Full Text] [Related]
6. Derivatives of 3-sec-butyl-1-oxo-2,3-dihydroisoquinoline as inhibitors of mu-calpain.
Chicharro R; Alonso M; Mazo MT; Arán VJ; Herradón B
ChemMedChem; 2006 Jul; 1(7):710-4. PubMed ID: 16902923
[No Abstract] [Full Text] [Related]
7. Developments in the design and synthesis of calpain inhibitors.
Neffe AT; Abell AD
Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145
[TBL] [Abstract][Full Text] [Related]
8. Novel cell-penetrating alpha-keto-amide calpain inhibitors as potential treatment for muscular dystrophy.
Lescop C; Herzner H; Siendt H; Bolliger R; Henneböhle M; Weyermann P; Briguet A; Courdier-Fruh I; Erb M; Foster M; Meier T; Magyar JP; von Sprecher A
Bioorg Med Chem Lett; 2005 Dec; 15(23):5176-81. PubMed ID: 16185867
[TBL] [Abstract][Full Text] [Related]
9. A novel series of urea-based peptidomimetic calpain inhibitors.
Sanders ML; Donkor IO
Bioorg Med Chem Lett; 2006 Apr; 16(7):1965-8. PubMed ID: 16412635
[TBL] [Abstract][Full Text] [Related]
10. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling, synthesis, and biological evaluation of macrocyclic calpain inhibitors.
Abell AD; Jones MA; Coxon JM; Morton JD; Aitken SG; McNabb SB; Lee HY; Mehrtens JM; Alexander NA; Stuart BG; Neffe AT; Bickerstaffe R
Angew Chem Int Ed Engl; 2009; 48(8):1455-8. PubMed ID: 19145612
[TBL] [Abstract][Full Text] [Related]
12. Primary amides as selective inhibitors of cathepsin K.
Léger S; Bayly CI; Black WC; Desmarais S; Falgueyret JP; Massé F; Percival MD; Truchon JF
Bioorg Med Chem Lett; 2007 Aug; 17(15):4328-32. PubMed ID: 17544269
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human mu-calpain by conformationally constrained calpastatin peptides.
Pfizer J; Assfalg-Machleidt I; Machleidt W; Schaschke N
Biol Chem; 2008 Jan; 389(1):83-90. PubMed ID: 18095873
[TBL] [Abstract][Full Text] [Related]
14. Exploration of peptidyl hydrazones as water-soluble calpain inhibitors.
Nakamura M; Inoue J
Bioorg Med Chem Lett; 2002 Jun; 12(12):1603-6. PubMed ID: 12039572
[TBL] [Abstract][Full Text] [Related]
15. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
Alper PB; Liu H; Chatterjee AK; Nguyen KT; Tully DC; Tumanut C; Li J; Harris JL; Tuntland T; Chang J; Gordon P; Hollenbeck T; Karanewsky DS
Bioorg Med Chem Lett; 2006 Mar; 16(6):1486-90. PubMed ID: 16412634
[TBL] [Abstract][Full Text] [Related]
16. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a small library of diketopiperazines as potential inhibitors of calpain.
Zeng Y; Li Q; Hanzlik RP; Aubé J
Bioorg Med Chem Lett; 2005 Jun; 15(12):3034-8. PubMed ID: 15896956
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling studies of peptide inhibitors highlight the importance of conformational prearrangement for inhibition of calpain.
Jiao W; McDonald DQ; Coxon JM; Parker EJ
Biochemistry; 2010 Jul; 49(26):5533-9. PubMed ID: 20499928
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.
Yoo YJ; Nam DH; Jung SY; Jang JW; Kim HJ; Jin C; Pae AN; Lee YS
Bioorg Med Chem Lett; 2011 May; 21(10):2850-4. PubMed ID: 21504847
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of chromone carboxamide derivatives with antioxidative and calpain inhibitory properties.
Kim SH; Lee YH; Jung SY; Kim HJ; Jin C; Lee YS
Eur J Med Chem; 2011 May; 46(5):1721-8. PubMed ID: 21397369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
